India's cheap weight-loss drugs could reshape global obesity fight
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
"Prices are expected to fall sharply."
— Sheetal Sapale , Other
"It is great that these will become cheaper so that more of the diabetic and obese Indian population can access them."
— Muffazal Lakdawala , Other
Key People
Locations
All Coverage
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
Similar Stories
Related coverage based on topic and tags
Indian police detain 'cockroach' movement founder Abhijeet Dipke - Reuters
Indian police detain 'cockroach' movement founder Abhijeet Dipke Reuters
October 10, 2026 at 05:27 AMIndia unveils tough curbs on dollar demand to defend rupee - Reuters
India unveils tough curbs on dollar demand to defend rupee Reuters
October 10, 2026 at 03:34 AMIndia detains protesters, locks down Delhi ahead of rally against election chief - Reuters
India detains protesters, locks down Delhi ahead of rally against election chief Reuters
October 10, 2026 at 12:33 AMThousands of security personnel deployed as Delhi braces for ‘cockroach’ protest
Several trains to Delhi have been cancelled and dozens of metro stations are shut to stop protesters from gathering.
October 9, 2026 at 11:02 PMBoots has a new owner: Three ways it could affect you
The stalwart of Britain's High Street has been sold to a Canadian billionaire family. What will that mean for you?
October 9, 2026 at 11:01 PMReport highlights flaws in ADHD and autism care
There is a risk of people being over-diagnosed with ADHD and autism, an official review in England has found.
October 9, 2026 at 01:52 PM